Matches in Nanopublications for { ?s ?p "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- NP678376.RAA-95amS3ZYqsS7p9G6Snavx4tR1Nnr7Y4hBHv9U4H60130_assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP678376.RAA-95amS3ZYqsS7p9G6Snavx4tR1Nnr7Y4hBHv9U4H60130_provenance.
- NP320055.RATTys2P-XTy3Yg9Fv6bx3zoFgkW1Ok2VGjBhIqEsvH64130_assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP320055.RATTys2P-XTy3Yg9Fv6bx3zoFgkW1Ok2VGjBhIqEsvH64130_provenance.
- NP578322.RAQIK-q4SYYEA__820gALVpETFseZK2ztA_K43r20H7KY130_assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP578322.RAQIK-q4SYYEA__820gALVpETFseZK2ztA_K43r20H7KY130_provenance.
- NP638697.RAo6IyKtMI2CAG4zWxKB2vIHx7q5kNCQXFrXlQaGfC7EU130_assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP638697.RAo6IyKtMI2CAG4zWxKB2vIHx7q5kNCQXFrXlQaGfC7EU130_provenance.
- assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP617448.RAykOu5V_QuSKSqqqnMlTVV7rdVzSftIgmU9S4GK0kzCI130_assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP617448.RAykOu5V_QuSKSqqqnMlTVV7rdVzSftIgmU9S4GK0kzCI130_provenance.
- NP632941.RA2vYx-i1e_tR-KF6Z4BtEidIBljUV8xymps1RCX8Vnbs130_assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP632941.RA2vYx-i1e_tR-KF6Z4BtEidIBljUV8xymps1RCX8Vnbs130_provenance.
- NP406759.RAOdWPtM9MhcJXp7fn23mmXX0ejoyIAOwtt5Mkn5is0F4130_assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP406759.RAOdWPtM9MhcJXp7fn23mmXX0ejoyIAOwtt5Mkn5is0F4130_provenance.
- NP902433.RAyW5Ih1vNq9PFiOKvLiMoZriKXcwOG38QX7KlAldE7Uo130_assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP902433.RAyW5Ih1vNq9PFiOKvLiMoZriKXcwOG38QX7KlAldE7Uo130_provenance.
- NP696488.RA3hyGL_j2MhbXDF1nRcyPNlJ9Z21p2lq3odJNEaRzwqA130_assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP696488.RA3hyGL_j2MhbXDF1nRcyPNlJ9Z21p2lq3odJNEaRzwqA130_provenance.
- NP734993.RARIpeCOe_430sDA0sL26U2VaXzdcHs2E3FHt5Evp2Dbw130_assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP734993.RARIpeCOe_430sDA0sL26U2VaXzdcHs2E3FHt5Evp2Dbw130_provenance.
- NP848282.RATFy71HLbBhPVr1b19wEY0vwLVfoLPfTKBPKeWGJQULc130_assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP848282.RATFy71HLbBhPVr1b19wEY0vwLVfoLPfTKBPKeWGJQULc130_provenance.
- NP679496.RAfYSrtipZcO4VJvvUwOUIqQl3W8FUBI_e-6H_louhQ7k130_assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP679496.RAfYSrtipZcO4VJvvUwOUIqQl3W8FUBI_e-6H_louhQ7k130_provenance.
- NP879841.RAazMfxI6EtRx6o6nXmlsb3rgqsNVxv2HPkM86YawpVUI130_assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP879841.RAazMfxI6EtRx6o6nXmlsb3rgqsNVxv2HPkM86YawpVUI130_provenance.
- assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP674880.RADRWw-ORs8LbyjUk-4mYG8AMP76fumGBjUzZduI-R7_k130_assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP674880.RADRWw-ORs8LbyjUk-4mYG8AMP76fumGBjUzZduI-R7_k130_provenance.
- NP786845.RACadgCP29exEZqlNJMA7YXYXq-vrB6uYnEUQi_9eeM5k130_assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP786845.RACadgCP29exEZqlNJMA7YXYXq-vrB6uYnEUQi_9eeM5k130_provenance.
- NP674882.RAWs1rlyk9A_FxO7FQQCibq0OHQjH4SD0igqm9Npubn0w130_assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP674882.RAWs1rlyk9A_FxO7FQQCibq0OHQjH4SD0igqm9Npubn0w130_provenance.
- NP822687.RAgseQPEYkmD9qCLDBOcX7Stc7zz8aE-14-FWGE55n4AI130_assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP822687.RAgseQPEYkmD9qCLDBOcX7Stc7zz8aE-14-FWGE55n4AI130_provenance.
- NP881605.RAhvq9V57Xan618A2KrCQ11D5vIHy9NjcvSyJMI3eQKWI130_assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP881605.RAhvq9V57Xan618A2KrCQ11D5vIHy9NjcvSyJMI3eQKWI130_provenance.
- NP674881.RAon857An_UTJK3UUd1y3Xwefn4Ff99AxEaJyS8OLa5Dg130_assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP674881.RAon857An_UTJK3UUd1y3Xwefn4Ff99AxEaJyS8OLa5Dg130_provenance.
- NP329109.RA5Kg25X5I2lmTr9tThg81gBLB6ASbRYDtYV2j1psAMpI130_assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP329109.RA5Kg25X5I2lmTr9tThg81gBLB6ASbRYDtYV2j1psAMpI130_provenance.
- NP326701.RA6ttiWAPhfpEuRghraKworvTeLUUDC7CkwDV9VdVm7Ww130_assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP326701.RA6ttiWAPhfpEuRghraKworvTeLUUDC7CkwDV9VdVm7Ww130_provenance.
- NP644228.RA_rM0FK5YGZ1Fm3KLUsL1VT-WdszDfJxnvCXiGcl8_QQ130_assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP644228.RA_rM0FK5YGZ1Fm3KLUsL1VT-WdszDfJxnvCXiGcl8_QQ130_provenance.
- NP674879.RAL748k_a45dVhK_TVK1qMKQZatqUacAOsnZ35ZWMuogE130_assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP674879.RAL748k_a45dVhK_TVK1qMKQZatqUacAOsnZ35ZWMuogE130_provenance.
- NP674883.RAJnU8HfAr71Fz1eBxt_bUKh5iBPjQ3RfM6l5LkzhMslk130_assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP674883.RAJnU8HfAr71Fz1eBxt_bUKh5iBPjQ3RfM6l5LkzhMslk130_provenance.
- NP674884.RAHy82s9944ruTON1R0nxw7HvwBzy-lGFhR1BkWrDCt0s130_assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP674884.RAHy82s9944ruTON1R0nxw7HvwBzy-lGFhR1BkWrDCt0s130_provenance.
- NP674886.RAIkWiCIKMdMchvIQf4-Wiwd41JeA-9ysWoO-sf_XgVBo130_assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP674886.RAIkWiCIKMdMchvIQf4-Wiwd41JeA-9ysWoO-sf_XgVBo130_provenance.
- NP674887.RAJlzDJ22w0wHoIhm0D4qMnc4YSt7DHG4MLxtET7gmCfw130_assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP674887.RAJlzDJ22w0wHoIhm0D4qMnc4YSt7DHG4MLxtET7gmCfw130_provenance.
- NP674878.RA9C6gkfDeIZ40LzDXg_j5FdLBX434eEdOtClr6EAOwkQ130_assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP674878.RA9C6gkfDeIZ40LzDXg_j5FdLBX434eEdOtClr6EAOwkQ130_provenance.
- NP674885.RA2nZXwv3L1-w7yO-45LYFpUomrHZSskGNF_3TdoTuFaE130_assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP674885.RA2nZXwv3L1-w7yO-45LYFpUomrHZSskGNF_3TdoTuFaE130_provenance.